News and features
Read the latest news and features about our world-leading research, discoveries, fundraising and philanthropy. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Educating the Next Generation of Researchers at The Institute of Cancer Research
In the ICR’s mission to relieve suffering due to cancer, major strategies include both education and the furthering of knowledge through scientific advancement. The programme of postgraduate research and taught training at the ICR both reflects these strategies and forms part of a commitment to the current and future pursuit of excellence in the fight against cancer.
Report reveals year of research success
The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust have launched their Joint Annual Research Report for 2010/11, highlighting a year of significant achievements.
Prostate cancer drug shows impressive new Phase III trial results
Patients with advanced prostate cancer who were given a new type of hormonal treatment called MDV3100 lived an extra 4.8 months compared to men taking a placebo, according to the full analysis of a Phase III trial.
Women with faulty BRCA genes more likely to survive ovarian cancer
Ovarian cancer patients who carry BRCA1 or BRCA2 mutations are significantly more likely to survive the disease than women without these faulty genes, according to research published in the Journal of the American Medical Association.
Musculoskeletal side–effects from breast cancer treatment not long term
A drug regimen found to cut a women’s risk of dying from breast cancer gives a higher risk of carpal tunnel syndrome, but this can be managed and does not persist once treatment has finished.
Scientists unravel cause of second cancer arising from targeted treatment
Scientists at The Institute of Cancer Research (ICR) have shown how to prevent new cancers which can occur when malignant melanoma patients are treated with drugs known as BRAF inhibitors, in a Cancer Research UK-funded study published today in the New England Journal of Medicine.
Scientist wins prestigious fellowship
A scientist from the ICR and The Royal Marsden has received one of four prestigious Cancer Research UK Clinical Scientist Fellowships for his research into new ways to detect and treat advanced prostate cancer.
Fewer, Larger Radiotherapy Doses Prove Safe For Prostate Cancer Patients
Less overall radiotherapy, delivered in fewer but higher doses, is as safe as standard, lower doses for treating prostate cancer, according to new research.
Scientists Discover How To Beat Resistance To Standard Leukaemia Drug
ICR scientists have revealed a technique to kill chronic myeloid leukaemia (CML) cells that have stopped responding to a targeted drug, according to research published in Cancer Cell
Scientist Recognised with Cancer Charity’s Highest Honour
The ICR's Professor Mel Greaves has become the first scientist honoured with leading blood cancer charity Leukaemia & Lymphoma Research's highest award.
Topping out ceremony marks milestone for The Royal Marsden and the ICR
Progress on The Royal Marsden and the ICR's new Centre for Molecular Pathology in Sutton, Surrey, has reached a major milestone with a topping out ceremony this week.
Global Award for Prostate Cancer Blood Test Developer
A scientist from the ICR and The Royal Marsden, Dr Timothy Yap, has received an award for ongoing work developing a blood test to predict how prostate cancer patients will respond to treatment.
